Sermorelin, tesamorelin, ipamorelin and CJC-1295 — with and without DAC — get bundled into the same telehealth checkout. They work through two different receptors and their half-lives differ by three orders of magnitude. That difference decides how often you inject, and it is the fastest way to see that these are not one product.
Elena Marchetti writes about peptide therapeutics and drug development. Last reviewed 4 September 2026.
Ranges stay ranges below. Where a source gives a span rather than a number, the band is that span — collapsing it to a midpoint would make the chart tidier and the figure wrong.
Scaffold notice, computed from the data rather than typed: the half-life figures above are the indicative ranges recorded in this project’s brand book and none of them yet carries a citation. They are placeholders. This notice disappears on its own once every molecule record has a source URL.
Attributes down, molecules across. On a narrow screen the attribute column stays put and the molecules scroll under it.
| Attribute | SermorelinSER | TesamorelinTES | IpamorelinIPA | CJC-1295 (no DAC)CJC | CJC-1295 + DACCJC-D |
|---|---|---|---|---|---|
| Mechanism | GHRH analog [needs citation] | GHRH analog [needs citation] | ghrelin mimetic [needs citation] | GHRH analog [needs citation] | GHRH analog [needs citation] |
| Half-life | 10–20 min [needs citation] | 26–38 min [needs citation] | ~2 hours [needs citation] | ~30 min [needs citation] | ~6–8 days [needs citation] |
| Cortisol / prolactin | not recorded | not recorded | does not raise cortisol or prolactin [needs citation] | not recorded | not recorded |
| FDA status | withdrawn [needs citation] | approved (Egrifta) [needs citation] | not approved [needs citation] | not approved [needs citation] | not approved [needs citation] |
| Commonly sold as | single agent, nightly [needs citation] | single agent, prescribed indication [needs citation] | stacked with CJC-1295 [needs citation] | stacked with ipamorelin [needs citation] | weekly dosing [needs citation] |
Head-to-head slices of the same grid: sermorelin vs ipamorelin and CJC-1295 vs sermorelin.
3 sellers listed. 2 of them pay us a commission and 1 does not; both kinds appear here, in the same format, and the label under each button says which is which. Full accounting on the disclosure page.
Every seller below is a placeholder record with a fictional price, kept here only to exercise the outbound mechanics. Nothing in this section describes a real company.
$189 per month — 300 mcg nightly · read 2026-09-02
Placeholder record. Prints a standing month-to-month rate before the intake and names its compounding pharmacy on the peptide page rather than only on the GLP-1 one.
See this seller’s peptide pageWe may be paid if you sign up through this link.
$205 per month — CJC-1295 + ipamorelin, 300 mcg nightly · read 2026-09-02
Placeholder record. Sells the stack rather than either molecule alone, so the figure is for the combination and is not comparable to a single-agent price.
Visit sellerWe may be paid if you sign up through this link.
from $99 per month — dose not stated · read 2026-09-02
Placeholder record, and not a partner. Leads with a floor price whose dose is not stated, so it is not comparable to a rate quoted against a dose.
Visit sellerWe are paid nothing if you sign up through this link.